Navigation Links
PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment

A team of researchers at Johns Hopkins Medical Institutions in Baltimore, Md., reports that whole-body positron emission tomography/computed tomography (PET/CT) scans may help physicians identify new, unexpected malignant cancerous tumors in patients, according to an article in the May issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine.

"PET/CT can help find additional lesions in patients known to have cancer," said SNM member Richard L. Wahl, M.D., director of nuclear medicine/PET at the Russell H. Morgan Department of Radiology and Radiological Science. PET/CT scans from nearly 2,000 cancer patients over a two-year period were evaluated retrospectively, explained Wahl, who was one of the first in the world and the first in this country to prove that PET could accurately diagnose breast cancer, melanoma and ovarian cancer and that it was superior to CT in staging lung cancer.

Wahl explained that in patients with known cancer, work-ups focus on a patient's primary disease and incidental coexistence of another primary malignant lesion can be missed. "Such newly identified lesions are often of early stage and have a better likelihood of being cured if treated promptly and aggressively," indicated Wahl, the senior author who co-wrote the JNM article, "Detection of Unexpected Additional Primary Malignancies With PET/CT," with SNM members Takayoshi Ishimori, M.D., Ph.D. (lead author), and Pavni V. Patel, M.D. Results of modern techniques such as PET/CT can be "potentially medically significant and relevant," said Wahl.

PET is a powerful medical imaging modality that noninvasively traces molecular and physiologic processes in the body. Currently, the most common use of PET is for whole-body oncologic imaging for diagnosis, staging, restaging and measuring early therapy responses. CT is an X-ray test that generates a detailed view of the anatomy or structure of organs and tissues in the body. Combining PET with CT provides images showing function (PET) and anatomy (CT) and a merged or "fused" picture of the body's metabolism and structure.


'"/>

Source:Society of Nuclear Medicine


Related biology news :

1. Fox Chase Cancer Center scientists identify immune-system mutation
2. Researchers identify target for cancer drugs
3. Scientists identify genetic pathways essential to RNA interference
4. Scientists identify molecular events that drive cell senescence
5. Scientists identify new model Of NK cell development
6. Chemists identify key gene in development of type 1 diabetes
7. Yale researchers identify molecule for detecting parasitic infection in humans
8. Wisconsin researchers identify sleep gene
9. Chemists identify immune system mechanism for methamphetamine binges
10. Biodiversity hotspots identify conservation priorities
11. Researchers identify protein crucial for survival of Lyme-disease bacterium
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... Market Research Future published a half cooked research report ... Security and Service Market is expected to grow over the CAGR ... Highlights: ... Mobile Biometric Security and Service Market is ... of authentication and security from unwanted cyber threats. The increasing use ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , the ... of its patent portfolio, which grew to over 40 granted and pending ... , , ... filed patent entitled " System, Device, and Method Estimating Force ... enables device makers to forego costly hardware components needed to estimate the ...
(Date:12/6/2016)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the "Company") ... million principal amount of its 1.414% senior unsecured notes due ... unsecured notes due 2026. The closing of ... to the satisfaction of customary closing conditions.  The notes will ... The Company intends to use the net proceeds from ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... Executive search firm Slone Partners ... commitment to the advancement of the clinical trials segment. Hosted in Miami, this ... trial planning and management. , As executive talent specialists in the industries ...
(Date:1/18/2017)... ... January 18, 2017 , ... Whitehouse Labs has furthered its ... Research, Inc. (AMRI), the scientific staff dedicated to Extractables / Leachables & Impurities ... growth in 2017. Extractable & Leachable evaluations have become increasingly more vital to ...
(Date:1/18/2017)... ... January 18, 2017 , ... MYOLYN, which creates medical ... submitted a 510(k) to the FDA, requesting clearance of the MyoCycle Home and ... (FES) technology. , The submission marks a major milestone for the technology ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, January 24-26). ... to examine vital clinical research issues such as trial performance metrics, patient enrollment ...
Breaking Biology Technology: